John Mendelsohn has retired from MD Anderson Cancer Center, which he served as president for 15 years, from 1996 to 2011.
Richard Pazdur, FDA’s top oncologist who last week received a battlefield promotion to the role of director of the FDA Center for Drug Evaluation and Research, is described as a stabilizing figure respected by major patient groups, oncology professional societies, and the industry.
